Multiple therapeutic options are available for the management of patients with upper urinary tract transitional cell carcinoma (TCC). Radical nephroureterectomy with an ipsilateral bladder cuff is the ...
SurvivorNet on MSN
Drug combination offers much-needed alternative for bladder cancer patients who can’t tolerate chemo
The VOLGA trial was the first to combine two immune checkpoint inhibitors with a targeted therapy in the perioperative ...
Patients with early-stage bladder cancer are often able to maintain their usual routines. Some may experience urinary ...
The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood ...
Urothelial carcinoma is the most common bladder cancer, with stage 1 indicating early-stage disease confined to the bladder lining. Diagnosis involves urinalysis, cystoscopy, TURBT, and imaging to ...
Bladder cancer remains difficult to treat once it becomes advanced, recurrent, or resistant to conventional therapies. A new ...
Bladder cancer is the fourth most commonly diagnosed cancer in men in the United States and the 10th leading cause of cancer deaths. Many treatments can be used for bladder cancer, and the kind of ...
JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...
Nat Clin Pract Urol. 2007;4(8):432-443. JD Raman is a Chief Resident in Urology and DS Scherr is an Assistant Professor of Urology at the New York Presbyterian Hospital–Weill Cornell Medical Center, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results